Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Apixaban

Apixaban

pharmaceutical raw materials
Apixaban structure

Apixaban 

structure
  • CAS No:

    503612-47-3

  • Formula:

    C25H25N5O4

  • Chemical Name:

    Apixaban

  • Synonyms:

    1H-Pyrazolo[3,4-c]pyridine-3-carboxamide,4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-;4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide;BMS 562247-01;Apixaban;Eliquis;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Apixaban is a highly selective, reversible inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively.

Apixaban Basic Attributes

459.504

459.50

Characteristics

111

2.2

1.42

770.468ºC at 760 mmHg

419.8±32.9 °C

1.705

Aqueous solubility: 40-50 μg/ml in 0.9% saline solutionAqueous solubility across the physiological pH range is approximately 0.04 mg/L

Store at 20 deg C to 25 deg C (68 deg F-77 deg F); excursions permitted between 15 deg C and 30 deg C (59 deg F-86 deg F).

4.29X10-18 mm Hg at 25 deg C (est)

Safety Information

P260, P264, P270, P314, P501

H372

Apixaban Use and Manufacturing

Apixaban, sold under the tradename Eliquis, is an anticoagulant for the treatment of venous thromboembolic events. It is taken by mouth. It is a direct factor Xa inhibitor.Apixaban was approved in Europe in 2012. It was approved in the U.S. in 2014 for treatment and secondary prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is being developed in a joint venture by Pfizer and Bristol-Myers Squibb.

Drug Function and Efficacy

It is an oral selective activated factor X inhibitor that can prevent thrombosis, but the adverse reaction of bleeding is lower than that of the old drug warfarin. It is used to prevent thrombosis in patients who have undergone hip or knee replacement surgery.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • METROCHEM API PRIVATE LTD

    United States United States
    Active
  • SRINI PHARMACEUTICALS PRIVATE LTD

    United States United States
    Active
  • MICRO LABS LTD

    United States United States
    Active

Recommended Suppliers of Apixaban

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.